Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Peripheral Retina Robotically Aligned OCT Study

NCT: NCT06451068 · WITHDRAWN

NCT IDNCT06451068
StatusWITHDRAWN
Start Date2026-01
Completion2026-03-31

Brief Summary

Optical coherence tomography (OCT) is a 3D imaging technology that has seen wide adoption within ophthalmology. However, optical access to the retinal periphery remains a challenge for conventional OCT systems. The study team plans to innovate peripheral retinal OCT imaging technology by first developing the first robotic OCT system capable of autonomously assisting the operator during imaging of the human peripheral retina using 3D active tracking and compensation and then by developing of the first OCT system designed for treatment of the retinal periphery.

Frequently Asked Questions

What is Peripheral Retina Robotically Aligned OCT Study?

Peripheral Retina Robotically Aligned OCT Study is a clinical trial registered under NCT06451068. Current status: WITHDRAWN.

What is the status of NCT06451068?

The current status of NCT06451068 (Peripheral Retina Robotically Aligned OCT Study) is: WITHDRAWN.

When did Peripheral Retina Robotically Aligned OCT Study start?

Peripheral Retina Robotically Aligned OCT Study started on 2026-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.